Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability

Social Cognitive and Affective Neuroscience

Volumn 11, Issue 8, 2016, Pages 1310-1316

  Karjalainen, Tomi ^a,b   Tuominen, Lauri ^a,b   Manninen, Sandra ^a   Kalliokoski, Kari K ^a   Nuutila, Pirjo ^a,c   Jääskeläinen, Iiro P ^b   Hari, Riitta ^b   Sams, Mikko ^b   Nummenmaa, Lauri ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

BAS; BIS; Carfentanil; Opioid; PET

Indexed keywords

CARFENTANIL; FENTANYL; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; OPRM1 PROTEIN, HUMAN;

ADULT; ANALOGS AND DERIVATIVES; BRAIN; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PUNISHMENT; REINFORCEMENT; REWARD; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; BRAIN; FEMALE; FENTANYL; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PUNISHMENT; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); REWARD; YOUNG ADULT;

EID: 84989222471     PISSN: 17495016     EISSN: 17495024     Source Type: Journal    
DOI: 10.1093/scan/nsw044     Document Type: Article

References (64)

1. Alenius, S., Ruotsalainen, U. (1997). Bayesian image reconstruction for emission tomography based on median root prior. European Journal of Nuclear Medicine, 24, 258-65.
2. Barrós-Loscertales, A., Meseguer, V., Sanjuán, A., et al. (2006a). Striatum gray matter reduction in males with an overactive behavioral activation system. European Journal of Neuroscience 24, 2071-4.
3. Barrós-Loscertales, A., Meseguer, V., Sanjuán, A., et al. (2006b). Behavioral inhibition system activity is associated with increased amygdala and hippocampal gray matter volume: a voxel-based morphometry study. NeuroImage, 33, 1011-5.
4. Beaver, J.D., Lawrence, A.D., van Ditzhuijzen, J., et al. (2006). Individual differences in reward drive predict neural responses to images of food. The Journal of Neuroscience, 26, 5160-6.
5. Beck, A.T., Steer, R.A., Garbin, M.G. (1988). Psychometric properties of the Beck Depression Inventory-twenty-five years of evaluation. Clinical Psychology Review, 8, 77-100.
6. Berridge, K.C., Robinson, T.E. (2003). Parsing reward. Trends in Neurosciences, 26, 507-13.
7. Berridge, K.C., Kringelbach, M.L. (2008). Affective neuroscience of pleasure: Reward in humans and animals. Psychopharmacology, 199, 457-80.
8. Berridge, K.C., Ho, C.Y., Richard, J.M., DiFeliceantonio, A.G. (2010). The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Research, 1350, 43-64.
9. Carver, C.S., White, T.L. (1994). Behavioral inhibition, behavioal activation, and affective responses to impending reward and punishment. Journal of Personality and Social Psychology, 67, 319-33.
10. Caseras, X., Ávila, C., Torrubia, R. (2003). The measurement of individual differences in behavioural inhibition and behavioural activation systems: a comparison of personality scales. Personality and Individual Differences, 34, 999-1013.
11. Colasanti, A., Rabiner, E., Lingford-Hughes, A., Nutt, D. (2011). Opioids and anxiety. Journal of Psychopharmacology, 25, 1415-33.
12. Coplan, R.J., Wilson, J., Frohlick, S.L., Zelenski, J. (2006). A personoriented analysis of behavioral inhibition and behavioral activation in children. Personality and Individual Differences, 41, 917-27.
13. Costumero, V., Barrós-Loscertales, A., Bustamante, J.C., et al. (2013). Reward sensitivity is associated with brain activity during erotic stimulus processing. PLoS ONE, 8, e66940.
14. Crockett, M.J., Clark, L., Robbins, T.W. (2009). Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. The Journal of Neuroscience, 29, 11993-9.
15. Deakin, J.F., Graeff, F.G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5, 305-15.
16. Depue, R.A., Collins, P.F. (1999). Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behavioral and Brain Sciences, 22, 491-517.
17. Fields, H.L. (2004). State-dependent opioid control of pain. Nature Reviews Neuroscience, 5, 565-75.
18. Dietrich, A., Federbusch, M., Grellmann, C., et al. (2014). Body weight status, eating behavior, sensitivity to reward/punishment, and gender: relationships and interdependencies. Frontiers in Psychology, 5, 1-13.
19. Fields, H.L., Margolis, E.B. (2015). Understanding opioid reward. Trends in Neurosciences, 38, 1-9.
20. Franken, I., Muris, P., Georgieva, I. (2006). Gray's model of personality and addiction. Addictive Behaviors, 31, 399-403.
21. Gorelick, D.A., Kim, Y.K., Bencherif, B., et al. (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biological Psychiatry, 57, 1573-82.
22. Gray, J.A. (1970). The psychophysiological basis of introversionextraversion. Behaviour Research and Therapy, 8, 249-66.
23. Gray, J.A. (1987). Perspectives on anxiety and impulsivity: a commentary. Journal of Research in Personality, 21, 493-509.
24. Gray, J.A., McNaughton, N. (2000) The Neuropsychology of Anxiety: an Enquiry into the Functions of the Septo-hippocampal System. 2nd edition. New York: Oxford University Press. p. 1-36.
25. Gunn, R.N., Lammertsma, A.A., Hume, S.P., Cunningham, V.J. (1997). Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage, 6, 279-87.
26. Hagelberg, N., Aalto, S., Tuominen, L., et al. (2012). Striatal m-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects. Neuroscience Letters, 521, 11-4.
27. Hahn, T., Dresler, T., Ehlis, A.C., et al. (2009). Neural response to reward anticipation is modulated by Gray's impulsivity. NeuroImage, 46, 1148-53.
28. Hariri, A.R., Mattay, V.S., Tessitore, A., et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297, 400-3.
29. Heinz, A., Reimold, M., Wrase, J., et al. (2005). Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. JAMA Psychiatry, 62, 57-64.
30. Heubeck, B.G., Wilkinson, R.B., Cologon, J. (1998). A second look at Carver and White's (1994) BIS/BAS scales. Personality and Individual Differences, 25, 785-800.
31. Hsu, D.T., Sanford, B.J., Meyers, K.K., et al. (2013). Response of the m-opioid system to social rejection and acceptance. Molecular Psychiatry, 18, 1211-7.
32. Johnson, S.L., Turner, R.J., Iwata, N. (2003). BIS/BAS levels and psychiatric disorder: an epidemiological study. Journal of Psychopathology and Behavioral Assessment, 25, 25-36.
33. Karlsson, H.K., Tuominen, L., Tuulari, J.J., et al. (2015a). Obesity is associated with decreased m-opioid but unaltered dopamine D2 receptor availability in the brain. The Journal of Neuroscience, 35, 3959-65.
34. Karlsson, H.K., Tuulari, J.J., Tuominen, L., et al. (2015b). Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Molecular Psychiatry, 21, 1057-62.
35. Kasch, K.L., Rottenberg, J., Arnow, B.A., Gotlib, I.H. (2002). Behavioral activation and inhibition systems and the severity and course of depression. Journal of Abnormal Psychology, 111, 589-97.
36. Kimbrel, N.A., Mitchell, J.T., Nelson-Gray, R.O. (2010). An examination of the relationship between behavioral approach system (BAS) sensitivity and social interaction anxiety. Journal of Anxiety Disorders, 24, 372-8.
37. Leknes, S., Tracey, I. (2008). A common neurobiology for pain and pleasure. Nature Reviews Neuroscience, 9, 314-20.
38. Leone, L., Perugini, M., Bagozzi, R.P., et al. (2001). Construct validity and generalizability of the Carver-White behavioural inhibition system/behavioural activation system scales. European Journal of Personality, 15, 373-90.
39. Lesscher, H.M.B., Bailey, A., Burbach, J.P.H., et al. (2003). Receptorselective changes in m-, d-and j-opioid receptors after chronic naltrexone treatment in mice. European Journal of Neuroscience, 17, 1006-12.
40. Love, T.M., Stohler, C.S., Zubieta, J.K. (2009). Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. JAMA Psychiatry, 66, 1124-34.
41. Lutz, P.E., Kieffer, B.L. (2013). Opioid receptors: distinct roles in mood disorders. Trends in Neurosciences, 36, 195-206.
42. Mague, S.D., Isiegas, C., Huang, P., et al. (2009). Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proceedings of the National Academy of Sciences of the United States of America, 106, 10847-52.
43. Mahler, S.V., Smith, K.S., Berridge, K.C. (2007). Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in Nucleus Accumbens Shell Enhances 'Liking' of a Sweet Reward. Neuropsychopharmacology, 32, 2267-78.
44. McConalogue, K., Grady, E.F., Minnis, J., et al. (1999). Activation and internalization of the m-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2. Neuroscience, 90, 1051-9.
45. Mick, I., Myers, J., Ramos, A.C., et al. (2015). Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers. Neuropsychopharmacology, 41, 1742-50.
46. Nummenmaa, L., Manninen, S., Tuominen, L., et al. (2015). Adult attachment style is associated with cerebral m-opioid receptor availability in humans. Human Brain Mapping, 36, 3621-8.
47. Papaleo, F., Kieffer, B.L., Tabarin, A., Contarino, A. (2007). Decreased motivation to eat in m-opioid receptor-deficient mice. European Journal of Neuroscience, 25, 3398-405.
48. Peciña, S., Berridge, K.C. (2000). Opioid site in nucleus accumbens shellmediates eating and hedonic "liking" for food:map based on microinjection Fos plumes. Brain Research, 863, 71-86.
49. Peciña, M., Love, T., Stohler, C.S., Goldman, D., Zubieta, J.K. (2015). Effects of the mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. Neuropsychopharmacology, 40, 957-65.
50. Pickering, A.D., Gray, J.A. (1999) The neuroscience of personality. In: Pervin, L.A., John, O.P., editors. Handbook of Personality: Theory and Research. 2nd edition. New York: The Guilford Press: p. 277-99.
51. Rajashekara, V., Patel, C.N., Patel, K., et al. (2003). Chronic opioid antagonist treatment dose-dependently regulates m-opioid receptors and trafficking proteins in vivo. Pharmacology Biochemistry and Behavior, 75, 909-13.
52. Salavert, J., Caseras, X., Torrubia, R., et al. (2007). The functioning of the behavioral activation and inhibition systems in bipolar I euthymic patients and its influence in subsequent episodes over an eighteen-month period. Personality and Individual Differences, 42, 1323-31.
53. Schwantes-An, T.H., Zhang, J., Chen, L.S., et al. (2015). Association of the OPRM1 variant rs1799971 (A118G) with nonspecific liability to substance dependence in a collaborative de novo meta-analysis of european-ancestry cohorts. Behavior Genetics, 1-19.
54. Simon, J.J., Walther, S., Fiebach, C.J., et al. (2010). Neural reward processing is modulated by approach-and avoidance-related personality traits. NeuroImage, 49, 1868-74.
55. Spielberger, C.D., Gorsuch, R.L., Lushene, R., et al. (1983) Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
56. Tuominen, L., Salo, J., Hirvonen, J., et al. (2012). Temperament trait Harm Avoidance associates with m-opioid receptor availability in frontal cortex: A PET study using [11C]carfentanil. NeuroImage, 61, 670-6.
57. Tuominen, L., Nummenmaa, L., Keltikangas-Järvinen, L., et al. (2014). Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems. Human Brain Mapping, 35, 1875-84.
58. Tuominen, L., Tuulari, J.J., Karlsson, H., et al. (2015). Aberrant mesolimbic dopamine-opioid interaction in obesity. NeuroImage, 122, 80-6.
59. Van Ree, J.M., Niesink, R.J.M., van Wolfswinkel, L., et al. (2000). Endogenous opioids and reward. European Journal of Pharmacology, 405, 89-101.
60. Weerts, E.M., Wand, G.S., Kuwabara, H., et al. (2011). Positron emission tomography imaging of mu-and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcoholism: Clinical and Experimental Research, 35, 2162-73.
61. Zhang, Y., Wang, D.X., Johnson, A.D., et al. (2005). Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. Journal of Biological Chemistry, 280, 32618-24.
62. Zhang, Y., Picetti, R., Butelman, E.R., et al. (2015). Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice. Neuropsychopharmacology, 40, 1091-100.
63. Zubieta, J.K., Gorelick, D.A., Stauffer, R., et al. (1996). Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nature Medicine, 2, 1225-9.
64. Zubieta, J.K., Smith, Y.R., Bueller, J.A., et al. (2001). Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science, 293, 311-5.